PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients
about
Escape from Lethal Bacterial Competition through Coupled Activation of Antibiotic Resistance and a Mobilized SubpopulationResponses of Pseudomonas aeruginosa to antimicrobialsGenome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutatorsNew amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharidesA divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A.An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin.Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneResistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients.In Vivo Evolution of Bacterial Resistance in Two Cases of Enterobacter aerogenes Infections during Treatment with ImipenemDirect detection of lipid A on intact Gram-negative bacteria by MALDI-TOF mass spectrometry.Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosaSecond Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent ToxicityMicroenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Bacterial stress responses as determinants of antimicrobial resistance.Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more.Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Transcriptional and mutational profiling of an aminoglycoside resistant Pseudomonas aeruginosa small colony variant.A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.Two-component systems required for virulence in Pseudomonas aeruginosa.In Vitro and In Vivo Efficacy of an LpxC Inhibitor, CHIR-090, Alone or Combined with Colistin against Pseudomonas aeruginosa Biofilm.The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions.Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditionsGene expression analysis in human polymorphonuclear leukocytes stimulated by LPSs from nosocomial opportunistic pathogens.Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.Extracellular DNA-induced antimicrobial peptide resistance mechanisms in Pseudomonas aeruginosa.In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital.
P2860
Q27309818-553B910C-3438-4443-A58C-A25408416950Q28305587-CD57C145-413A-4768-A73F-A05631C1D852Q28536866-1295CE6F-02A2-47B3-96DD-8CC21DCD576DQ28654498-C017D890-7658-43F1-9FFE-754BA79F284CQ30153476-055C9687-048D-4561-A393-20D9FDBDBA1AQ33895055-7F465794-F201-4253-B1D9-F2F1CF456BA7Q33911762-36C33EB1-65C8-47A3-9F7B-15B85A1281EBQ34058244-522E8925-DA5A-4F92-877F-F998F25E15BCQ34446329-41216543-B60C-47C8-9C26-3E8D72B1CB07Q34552966-305F74F5-8F0C-4B13-9D2A-CC32B545F731Q34565049-999BF08F-DD90-4555-991A-DF908142C34FQ35785140-E2E93B2B-DEDA-48E5-BE1D-1E172AA2DF08Q35865963-4AD96921-67F1-4E81-B3A8-4A2018F32BF8Q36018883-35E38CC7-4BF9-4AD9-A52C-2303784811EAQ36037546-7595BE3A-E962-4784-8905-0C542F0D4F6FQ36080468-83E35ACE-A771-4335-A1EC-DB8B4B9DDD6EQ36346231-D4B6CD40-A5F1-4A86-9213-D1B854F0E556Q36785850-7BCFAA74-0D5D-4799-9BB0-09E2873DB284Q36785893-C58A4981-848C-4D8B-8462-158092B77EA4Q37014270-DDC17682-63E0-4914-BD31-4DA1366A684CQ37223605-6C0AE9CF-FF1F-4462-A516-DC7529E18033Q37634327-4DF72C56-E6E0-4496-A6AB-F8EDE20CEA30Q37643058-A30B1F5D-063B-4178-927A-5991F3E3DE19Q38012391-7886371B-025B-4FE3-91CE-A0C6354EBB5FQ38267242-F279F21A-8C33-42DD-B927-28E6F61DC9A0Q38287949-70D2E8A2-62AF-4371-BB15-861B29DBB202Q38741337-EE343CB0-B420-459F-A8E0-73A221787CB5Q40056971-5DC24A4E-5F25-409E-A99D-26B67C19E49DQ40065990-EAF8AC0B-73DA-42BD-A8AC-5478382EECC7Q40112398-95D0CA4B-C811-49B2-A534-5C282314AB3AQ40166144-7054559A-621D-4094-8AC6-A84DD19AA9BBQ40210470-1E47AA90-E212-448D-BBA5-FF7ACD534532Q40230660-C3386C53-0A34-4C7E-878D-D9C923EAF337Q40519553-C0FC316E-4350-45E9-8237-F2FB8F3F5F74Q40956744-52B2CBDB-C9A1-4D50-9266-B578CF773B86Q40996390-F20C58A7-F076-4392-BE8F-21E17D53ED75Q41758615-6C9B6E28-8C96-47B4-B899-4369C191B924Q41836482-8C8CB751-EA55-426D-A986-5E11E03E221AQ41857059-8BAAB1DB-053B-4811-AB4B-AED310D4F5D5Q41877562-93EE29A5-4F88-439D-80E5-EB0F71E0D059
P2860
PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@ast
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@en
type
label
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@ast
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@en
prefLabel
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@ast
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@en
P2093
P2860
P356
P1476
PmrB mutations promote polymyx ...... eated cystic fibrosis patients
@en
P2093
Amanda K Miller
Helle K Johansen
Mark K Brannon
Miles Denton
Miyuki Pier
Nandini Dasgupta
Nicole Sgambati
Samuel I Miller
Samuel M Moskowitz
Sara E Selgrade
P2860
P304
P356
10.1128/AAC.05829-11
P407
P50
P577
2011-11-21T00:00:00Z